The data valuation layer for preventive personalised health

We develop a technology for health data valuation that is based on Federated Learning, advanced ageing biomarker models, and the principles of behavioural economics.

Unlocking the value of data for health innovation

  • Data as an asset class for company valuations
  • Fair contribution assessment across data value chains
  • Incentives to share data
  • User engagement and trust
  • Health Economics models augmented by AI
  • Standards and best practices for regulatory compliance

All-Parliamentary Group for Longevity


AJAX was selected as one of the three case-studies by the APPG Open Life Data working group. Download the report.

Supported by

Send a Message